Abstract: A steering unit for conveying devices on wheels such as beds, stretchers or trolleys includes a wheel unit and a motor unit. The wheel unit includes a base structure and a wheel mounted on a supporting element to rotate about an axis. The supporting element is mounted on the base structure to rotate about an orientation axis. A transmission includes an inlet unit and outlet shaft. The inlet unit includes an engagement device to reversibly engage the inlet unit on a transmission unit of the motor unit. The outlet shaft is integral with the supporting element and defines the orientation axis. The transmission transforms an inlet motion of the inlet unit into an outlet rotation of the outlet shaft about the orientation axis. A motor includes a complementary engagement device operating with the engagement device for reversibly engaging the inlet unit on the transmission unit.

Abstract: A steering unit for conveying devices on wheels such as beds, stretchers or trolleys includes a wheel unit and a motor unit. The wheel unit includes a base structure and a wheel mounted on a supporting element to rotate about an axis. The supporting element is mounted on the base structure to rotate about an orientation axis. A transmission includes an inlet unit and outlet shaft. The inlet unit includes an engagement device to reversibly engage the inlet unit on a transmission unit of the motor unit. The outlet shaft is integral with the supporting element and defines the orientation axis. The transmission transforms an inlet motion of the inlet unit into an outlet rotation of the outlet shaft about the orientation axis. A motor includes a complementary engagement device operating with the engagement device for reversibly engaging the inlet unit on the transmission unit.

Abstract: New process for the synthesis of the levodopa, L-(-)-2-amino-3-(3,4-dihydyphenyl)propionic acid, drug used in the treatment of the Parkinson's disease. The process consists in resolving with d-camphorsulfonic acid, or with a salt thereof, the d,l-2-amino-3-(3,4-dimethoxyphenyl)propionitrile, obtained from the 3,4-dimethoxyphenylacetaldehyde, and in the subsequent hydrolysis and demethylation, by means of concentrated solutions of haloid acids, of the d-2-amino-3-(3,4-dimethoxyphenyl)propionitrile and of salts thereof.

Abstract: A new process for the optical resolution of racemic mixtures of .alpha.-naphthylpropionic acids of formula ##STR1## wherein R.sub.1 is (C.sub.1-6) alkyl and R.sub.2 represents hydrogen or a halogen atom comprises reacting a racemic mixture of a compound of formula II ##STR2## wherein R.sub.1 and R.sub.2 have the above seen meanings and R.sub.3 is a reactive group, with an optically active aminoacid of formula ##STR3## wherein R.sub.4 represents a (C.sub.1-8) alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl or carboxy, and m is an integer from 0 to 4, to give a pair of diastereoisomeric amides of formula ##STR4## wherein R.sub.1, R.sub.2, R.sub.4 and m have the above seen meanings, and M is a hydrogen atom or a cation of an alkali metal or a cation of an organic base. Compounds IV are resolved into the single diastereoisomeric amides d,d or 1,d, or d,1 or 1,1. Acid hydrolysis gives the optically active compound I.

Abstract: Derivatives of benzoylphenoxyalkanoic acids corresponding to the formula: ##STR1## wherein: X represents for example a halogen, R.sup.1 and R.sup.2 represent for example alkyl groups, R represents for example an aminoacid; and the salts thereof are new products showing antilipaemic and anticholesterolemic pharmacological activity.

Abstract: New compounds of general formula ##STR1## and salts therewith of pharmaceutically acceptable acids, wherein R and R.sub.1 independently represent a hydrogen atom or a straight or branched alkyl group having from 1 to 5 carbon atoms, and n is an integer from 4 to 12; and of general formula ##STR2## wherein R'.sub.1 represents a straight or branched alkyl group having from 2 to 4 carbon atoms, W represents hydroxymethyl or the COOM group in which M stands for a hydrogen atom, an alkali metal or an equivalent of an alkali earth metal and n is an integer from 6 to 8. The compounds are useful in treating hyperlipidaemia.

Abstract: Derivatives of benzoylphenoxyalkanoic acids corresponding to the formula: ##STR1## wherein: X represents for example a halogen, R.sup.1 and R.sup.2 represent for example alkyl groups, R represents for example an aminoacid; and the salts thereof are new products showing antilipaemic and anticholesterolemic pharmacological activity.

Abstract: Derivatives of benzoylphenoxyalkanoic acids corresponding to the formula: ##STR1## wherein: X represents for example a halogen, R.sup.1 and R.sup.2 represent for example alkyl groups, R represents for example an aminoacid; and the salts thereof are new products showing antilipaemic and anticholesterolemic pharmacological activity.